The test named the "SARS-CoV-2 DETECTR" is easy to implement and to interpret, and requires no specialised equipment, said researchers from the University of California, San Francisco in the US.
Global pharmaceutical major Teva is planning collaborations with Indian partners for clinical research and biotechnology.
India and the Netherlands on Tuesday signed a memorandum of understanding for cooperation in biotechnology with an aim to find solutions to problems in agricultural and health
Knowledge of technical skills, creativity, social and emotional intelligence is what recruiters are looking for.
The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.
According to medical practitioners, the treatment is especially useful in controlling disease among those who have not received the vaccine or got only one shot and also the high-risk contacts of a patient.
India and America sign an agreement to jointly pursue reasearch in vision care.
In a weekly series, CollegePond.com provides answers all your queries related to pursuing an education abroad.
The 'Age of Rage' survey by Tata Salt Lite revealed some startling facts about the causes of stress and anxiety among urban Indians.
Asserting that India offers unprecedented opportunities for entrepreneurs in biotechnology industry, Minister of State for Science and Technology Kapil Sibal has invited venture capitalists, experts in the field and non-resident Indians to invest the
By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.
Cadila, Biocon developing rapid antibody testing kits; Eris, Mylan, Gland importing. There are two kinds of testing for the novel coronavirus - the real-time polymerase chain reaction test kit that uses throat or nasal swabs and provides results in a few hours, and the other is antibody-based rapid testing kit that use blood samples and provides results in a few minutes.
Green revolution and technology use should not be region-specific.
Three TMC leaders Amit Mitra, Bratya Basu and Rathin Ghosh were sworn-in virtually. Mitra is unwell and both Basu and Ghosh are recuperating from COVID-19.
India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six months at minus 20 degrees Celsius, reports Sohini Das.
A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.
The Institute of Bioinformatics and Applied Biotechnology, Bangalore, announces admissions for its third batch, 2004-2005.
Biotechnology industry worldwide is poised to achieve profitability by 2010, offering an opportunity to Indian companies to strike alliances with global firms.
The serious glitches in the Biotechnology Regulatory Authority of India Bill.
Learn how the founder of India's first and largest biotechnology company dealt with failure and achieved success.
Addressing a press briefing, Union Health Secretary Rajesh Bhushan said healthcare workers and frontline workers need not register themselves as their database has been populated on to the Co-WIN vaccine delivery management system in a bulk manner.
Finance Minister Nirmala Sitharaman on Thursday announced a new job creation scheme by giving subsidy to those establishments that make new hires. The subsidy would be to cover for retirement fund contributions by employees as well as employers for two years, she said. Employees contribution (12 per cent of wages) and employer's contribution (12 per cent of wages) totalling 24 per cent of wages would be given to establishments for two years, she said. Under the Aatmanirbhar Bharat Rozgar Yojana, every Employees' Provident Fund Organisation (EPFO)-registered establishment taking new employees would get this subsidy.
India's biotech industry has a vast potential for bilateral cooperation with US firms for collaborative research, technology trade, licensing and distribution.\n\n\n\n
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances